150 results about "Drug regimen" patented technology

A cost estimation tool, preferably a handheld computer, prices and evaluates the financial impact of new residents' prior to admission. Immediate access to this information and built-in therapeutic substitution and clinical advisories provides the opportunity to optimize pharmaceutical regimens prior to admission. In addition, an abbreviated Resource Utilization Group (RUG) evaluation function provides a rapid assessment tool to project reimbursement under the Medicare Prospective Payment System (PPS). A user may enter a complete drug regimen and estimate the costs for the regimen. Similarly, managed care reimbursement from managed care organizations (MCOs) to be analyzed. Also, drug cost may be estimated through a MEDICAID Preferred Drug List database that identifies potential Non-Preferred drugs that may be non-compensable. The present invention further transmits results wirelessly to health care providers.

A repeat prescription ordering system for allowing patients requiring resupply of medication or medical products to access a server using a portable communications and data processing device such as a smart phone or personal digital assistant. The server supplies to the patient a list of medication and medical products which they are authorized to order. The patient can select the products required, and the order is logged by the server and allocated to a supplier for completion of the order. The server maintains an estimate of the amount of medication or medical product held by the patient, this being based on the prescribed dosage regimen and information entered by the patient on their usage and, optionally, on checks on their own health. The patient may be alerted when the estimate indicates that their supplies are running low. The estimate is allowed to go below zero, this implying a possible departure from the prescribed medication regimen.

A device for identifying a drug, the device including at least one sensor for sensing and recording selected characteristics of a drug to be identified for compatibility with a pre-selected drug regimen, elements for transferring the recorded characteristics for analysis, elements for receiving analyzed data of the recorded characteristics, and a display for displaying the received data.

A dosage form is disclosed comprising means for delaying the delivery of drug from the dosage form following the administration of the dosage form to a patient in need of drug therapy.

An embodiment of the present invention is a method for measuring activity of cell pathways, such as the cell cycle pathway and correlating the resulting profile to phenotypes. The resulting correlations are useful in diagnosis, prognosis, selection and development of drug treatment regimens, and drug screening applications.

An automated small items dispensing apparatus is disclosed. In a preferred embodiment, the invention includes a networked, programmable, automatic medication items dispensing apparatus for use by individual patients who are enrolled in a medication protocol or medication therapy regimen. The device is located separate from the patient's health care provider's facility, such as in the patient's home.

A method is provided for encouraging patient compliance with a medicine regimen that includes interaction with the patient. The method includes the steps of providing a database which includes information regarding each patient. Information is supplied to the database by smart packages and other stakeholders. The information in the database is used to construct a patient report that may be viewed by the patient and others. Information in the patient report includes data on the patient's compliance, side effects of the medicine, expected results, interactions with other medicines, statements complimenting compliance, and warnings discouraging non-compliance. The patient report may be accessed by a common communication means such as the Internet.

A dosage form is disclosed comprising means for delaying the delivery of drug from the dosage form following the administration of the dosage form to a patient in need of drug therapy.

A system and method for detecting improper drug use utilizes the morphine equivalency of a drug regimen of a patient having an injury to compare the morphine equivalency of the drug regimen of the patient to that of a peer group having the same diagnosis. The comparison may be conducted based on the aggregate morphine equivalency for respective periods of time following the injury or the initial treatment and based on the rate of change in the morphine equivalency for that or another period of time. Based on the results of the comparison, potential instances of drug fraud and / or drug abuse are identified and an alert is generated, and appropriate action is taken, where needed.

A method for dynamic control of medications provided to a patient at a remote location is disclosed. The method can include steps of selecting a customized set of medications for a patient, where the customized set of medications at least partially reflect a medical diagnosis of the patient, and providing the customized set of medications to the patient, where the customized set of medications are inaccessible to the patient without authorization from a medical care provider. Further steps of the method can include authorizing the patient to receive a first medication regimen from the customized set of medications, monitoring remotely at least one health parameter of the patient, and authorizing the first medication regimen to be modified to a second medication regimen based at least partially on the at least one health parameter.

A medication dispenser is provided which includes compartments uniquely arranged with respect to time, for example, by time of day and / or day of week. Each compartment may contain pills in accordance with a pharmaceutical regimen such that consuming the pills within the compartments at the appropriate time as arranged with respect to time may maintain a patient's compliance with the pharmaceutical regimen. Additionally, a medication compliance and management method is provided which includes the steps of a) reviewing a pharmaceutical regimen of a patient to reduce a complexity of the pharmaceutical regimen, b) providing a quantity of medication dispensers in accordance with the reviewed pharmaceutical regimen with pills of the pharmaceutical regimen organized within the medication dispensers to further reduce the complexity of the pharmaceutical regimen, c) tracking the quantity of provided medication dispensers to determine when the quantity of medication dispensers will be depleted, d) contacting a prescribing doctor to obtain authorization to refill additional medication dispensers, and e) delivering refilled medication dispensers to the patient.

Without timely reminders, certain individuals may be highly unlikely to complete various tasks scheduled for completion. For example, medicinal therapy regimen patients often have difficulty in remembering to take their prescribed medications in accordance with care provider specified instructions. By providing a reminder prompt generation system that utilizes machine-learning and / or artificial intelligence to determine appropriate reminder times and modalities for providing automated-prompting notifications to users, the users' adherence to scheduled task completions can be significantly increased.

Described herein is a system for monitoring gene expression for diagnosing and monitoring inflammation disorders, and for monitoring gene expression in inflammation disorders in response to a particular drug treatment reginmen. This system for detecting nucleic acid expression in a body fluid uses an isolated polynucleotide to detect expression of a nucleic acid comprising a nucleotide sequence selected from the group consisting of SEQ ID NO: 5; SEQ ID NO:11; SEQ ID NO:17; and SEQ ID NO: 23. These nucleic acids are differentially expressed in body fluid in an individual with a disease criterion for a disease as listed in Table 1 as compared to an individual without the disease criterion.

A system and method of identifying patients with an increased risk for medication misuse as a result of their physical condition or inability to follow a prescription drug regimen. This is accomplished by an onsite evaluation of the patient, their physical condition and medication usage, including prescriptions, over the counter medications, herbals and food interactions, by a qualified individual. The results of this evaluation are provided to a database that generates a report comprising a patient's vital signs, medication interactions, prescription changes, prescription renewals, discontinued medications, evaluation of a patient's compliance with their medication regimen and education approved for to assist the patient with their compliance for review by the patient's primary care physician, additional physicians treating the patient, authorized organizations, such as HMOs, gardians or other authorized individual. With this knowledge the physician can identify a current or potential problem and can recommend changes to a patient's prescription drug regimen or education regarding drug regimens to correct the problem.

A medication reminder system is provided for allowing patients, especially those with memory or eyesight problems, to improve compliance with a medication regimen that has been prescribed by their physician. The system is organized for ease of patient identification by recording medications in blank or color-coded fields upon a sheet to match an indicator associated with a medication container. The sheet also includes markings associated with some or all of the medications which provide a way for the patient to gain more information about the medication.

Cardiac treatment methods and devices providing templates representative of past tachyarrythmia events, each template associated with a therapy. A cardiac waveform is detected, and if it corresponds to a particular template associated with a previous therapy that was satisfactory in terminating a past event, the previous therapy is delivered again. If unsatisfactory, the previous therapy is eliminated as an option. If, for example, the previous therapy was an antitachycardia pacing therapy unsatisfactory in terminating the past tachyarrythmia event, delivery of the antitachycardia pacing therapy is eliminated as an option. Instead of ATP therapy, one or more of a cardioversion, defibrillation, or alternate anti-tachycardia pacing therapy may be associated with the particular template. Cardiac waveforms and templates may correspond in terms of one or more of morphology, timing, drug regimen, medication, neural activity, patient activity, hemodynamic status, cardiac tissue impedance, transthoracic impedance, or other information corresponding to the episode.

A method and apparatus for monitoring drug-regimen compliance is disclosed. Systems in accordance with the present invention enable automatic monitoring of the state of medicine content of a blister card. Each tablet location on the blister card is operatively coupled with a different sensor that detects whether the tablet location is occupied and / or a dispensing event at a tablet location. In some embodiments, capacitive sensing is employed, where the capacitance of each sensor is based on the physical state of a dispensing region of the lidding film of the blister pack, which is located at the tablet location being monitored. Alternative sensing approaches are based on optical, acoustic, and tactile sensors that interrogate either the dispensing region at each tablet location or the tablets themselves to determine whether tablets have been dispensed. The sensors interface with a mobile app that provides the user instructions to help improve drug-regimen compliance.

A medication reminder and compliance system including a pill box, a pill box and electronic device; or a pill box, electronic device and remote server. The pill box includes several detachable dosettes, each divided into several chambers having a door. A two-color LED is disposed beneath each chamber and is activated when a specific reminder time is reached. The LED initially illuminates the associated chamber with a green light but changes to a flashing red light if the door is not opened within a preset time. A switch engaged with the door deactivates the LED when the door is opened. The electronic device communicates with the pill box and alerts the patient when it is time to take medication. A remote server which communicates with both the pill box and electronic device can be programmed to control the reminder schedule and monitor the patient's compliance with a prescribed medication regimen.

Disclosed is an apparatus and system for monitoring drug regimen compliance, the system utilizing a Radio Frequency Identification (RfID) tag affixed to a pharmaceutical agent and a wearable RFID reader that identifies a patient. The RFID tag identifies the pharmaceutical agent and the RFID reader wirelessly communicates with a central monitoring system upon ingestion of the pharmaceutical agent.

A system and method for increasing patient adherence to following medication treatment regimens. An adherence data processing and communication system generates and displays medication adherence data based on historical medication information. The system is linked to other systems involved with electronic ordering and filling of prescriptions, such as electronic prescription and pharmacy systems all connected by suitable wired and / or wireless communication protocols including the Internet. In one embodiment, the adherence data is displayed in the form of an interactive report card which provides a user with adherence metrics in both summary and more detailed formats for prescription medications taken by the patient. A related method executed by the data processing and communication system is disclosed.

The present invention discloses a method for determining the efficacy of GPC3-targeting drug therapy for cancer in a patient before the start of GPC3-targeting drug therapy or a patient or determining the continuation of GPC3-targeting drug therapy for a patient, including monitoring a concentration of free GPC3 in a biological sample isolated from the patient before the start of GPC3-targeting drug therapy and / or the patient treated with the GPC3-targeting drug therapy, wherein when the concentration of free GPC3 is a predetermined value, the efficacy of the GPC3-targeting drug therapy is determined or the continuation of the GPC3-targeting drug therapy is determined. The present invention also discloses a GPC3-targeting drug or a preparation which is to be further administered to a patient for which the efficacy of the GPC3-targeting drug therapy has been determined or the continuation of the GPC3-targeting drug therapy has been determined.

A method of providing items required for a complex drug regimen. In a preferred embodiment the method includes the steps of disposing a plurality of different drugs in corresponding drug compartments within a container; and providing drug identification information visually associated with each drug compartment containing a drug. The invention also includes a kit for a complex drug regimen. In a preferred embodiment the kit includes a kit container including a plurality of drug compartments, each drug compartment adapted to contain a drug; a plurality of different drugs disposed in the drug compartments; and drug identification information visually associated with each drug compartment containing a drug.

The invention provides antineoplastic composition containing an inhibitor of angiogenesis and an inhibitor of DNA topoisomerase type I enzyme activity.

The invention discloses medicine for treating milch cow postpartum retention of placenta, which is prepared with the following Chinese traditional medicines in certain weight portions: astragalus, lanceolata, atractylodes, roasted ginger, cinnamon, angelica, rhizome ligustici chuanxiong, salvia, peach kernel, safflower, achyranthes root, olibanum, myrrh, hawthorn and radix auckladiae. The medicine with the invention has 100 percent of effective rate on the treatment of milch cow postpartum retention of placenta, 99 percent of cure rate and significant curative effect; the disease can be cured with the medicine, the curative effect is definite after use, an unserious cow can be cured in one course, a serious cow can be cured in two courses, and one course is one to two days.